PortalPublikationenSuccessful Immunochemotherapy for Burkitt Lymphoma During Pr...

Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy

Standard

Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy : A Case Report and Review of the Literature. / Stang, Axel; Schwärzler, Peter; Schmidtke, Susanne; Tolosa, Eva; Kobbe, Robin.

in: CL LYMPH MYELOM LEUK, Jahrgang 20, Nr. 6, 06.2020, S. e284-e290.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Stang, A, Schwärzler, P, Schmidtke, S, Tolosa, E & Kobbe, R 2020, 'Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature', CL LYMPH MYELOM LEUK, Jg. 20, Nr. 6, S. e284-e290. https://doi.org/10.1016/j.clml.2019.12.012

APA

Stang, A., Schwärzler, P., Schmidtke, S., Tolosa, E., & Kobbe, R. (2020). Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature. CL LYMPH MYELOM LEUK, 20(6), e284-e290. https://doi.org/10.1016/j.clml.2019.12.012

Vancouver

Stang A, Schwärzler P, Schmidtke S, Tolosa E, Kobbe R. Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature. CL LYMPH MYELOM LEUK. 2020 Jun;20(6):e284-e290. https://doi.org/10.1016/j.clml.2019.12.012

Bibtex

@article{9c3b41a8bf29447686784be88f5bd1bd,
title = "Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature",
keywords = "Adult, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Burkitt Lymphoma/therapy, Cyclophosphamide/administration & dosage, Cytarabine/administration & dosage, Doxorubicin/administration & dosage, Etoposide/administration & dosage, Female, Humans, Immunotherapy, Methotrexate/administration & dosage, Postpartum Period, Prednisolone/administration & dosage, Pregnancy, Pregnancy Complications, Neoplastic/therapy, Rituximab/administration & dosage, Vincristine/administration & dosage",
author = "Axel Stang and Peter Schw{\"a}rzler and Susanne Schmidtke and Eva Tolosa and Robin Kobbe",
year = "2020",
month = jun,
doi = "10.1016/j.clml.2019.12.012",
language = "English",
volume = "20",
pages = "e284--e290",
journal = "CL LYMPH MYELOM LEUK",
issn = "2152-2650",
publisher = "Cancer Media Group",
number = "6",

}

RIS

TY - JOUR

T1 - Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy

T2 - A Case Report and Review of the Literature

AU - Stang, Axel

AU - Schwärzler, Peter

AU - Schmidtke, Susanne

AU - Tolosa, Eva

AU - Kobbe, Robin

PY - 2020/6

Y1 - 2020/6

KW - Adult

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage

KW - Burkitt Lymphoma/therapy

KW - Cyclophosphamide/administration & dosage

KW - Cytarabine/administration & dosage

KW - Doxorubicin/administration & dosage

KW - Etoposide/administration & dosage

KW - Female

KW - Humans

KW - Immunotherapy

KW - Methotrexate/administration & dosage

KW - Postpartum Period

KW - Prednisolone/administration & dosage

KW - Pregnancy

KW - Pregnancy Complications, Neoplastic/therapy

KW - Rituximab/administration & dosage

KW - Vincristine/administration & dosage

U2 - 10.1016/j.clml.2019.12.012

DO - 10.1016/j.clml.2019.12.012

M3 - SCORING: Review article

C2 - 32165154

VL - 20

SP - e284-e290

JO - CL LYMPH MYELOM LEUK

JF - CL LYMPH MYELOM LEUK

SN - 2152-2650

IS - 6

ER -